Sign In
Buy ABT
$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
Abbott Labs Posts Higher Sales, Reaffirms Outlook
07:55am, Wednesday, 15'th Oct 2025
Abbott Laboratories backed its full-year outlook after posting higher sales in the third quarter, boosted by sales of its nutrition shakes and drinks for adults
Abbott posts higher quarterly revenue on strong medical device demand
07:36am, Wednesday, 15'th Oct 2025
Abbott reported higher quarterly revenue on Wednesday, driven by strong demand for its medical devices including continuous glucose monitors and heart devices.
Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance
07:30am, Wednesday, 15'th Oct 2025
Third-quarter reported sales growth of 6.9 percent; organic sales growth of 5.5 percent or 7.5 percent excluding COVID-19 testing-related sales1 Third-quarter GAAP diluted EPS of $0.94; adjusted dilut
Stock Market Today: Nasdaq, Dow Jones Futures Rise, Bank Of America, Morgan Stanley, Abbott In Focus—Analyst Warns US 'Going Broke Slowly'
05:59am, Wednesday, 15'th Oct 2025
U.S. stock futures advanced on Wednesday following Tuesday's mixed close. Futures of major benchmark indices were higher.
Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
10:56am, Monday, 13'th Oct 2025
Abbott Laboratories (NYSE:ABT) will release earnings results for the third quarter, before the opening bell on Wednesday, Oct. 15.
Worried Investors Should Look at the 5 Safest Dividend Kings Right Now
10:12am, Monday, 13'th Oct 2025
First, it was David Solomon from Goldman Sachs, then Jamie Dimon from J.P.
Wall Street Week Ahead
06:57am, Sunday, 12'th Oct 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Wall Street's Insights Into Key Metrics Ahead of Abbott (ABT) Q3 Earnings
10:16am, Friday, 10'th Oct 2025
Evaluate the expected performance of Abbott (ABT) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 10'th Oct 2025
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Abbott to Report Q3 Earnings: Medical Devices Arm in Focus
09:46am, Friday, 10'th Oct 2025
ABT's Q3 results may show strength in Medical Devices and Nutrition, offsetting softness in Diagnostics.
Abbott Laboratories: There May Be A Surge Coming Next Week (Earnings Preview)
07:37am, Thursday, 09'th Oct 2025
Abbott Laboratories is set to report Q3 earnings, with EPS expectations of $1.30, reflecting 8.3% YoY growth. Abbott's Q2 results showed strong earnings growth, but the stock fell due to expectations
Ventric Health Appoints Managed Care Veteran Christopher Abbott to Board of Directors
08:00am, Monday, 06'th Oct 2025
PASADENA, Calif.--(BUSINESS WIRE)-- #VentricHealth--Ventric Health appoints managed care veteran Chris Abbott to its Board of Directors ahead of commercial expansion of its FDA-approved Vivio System.
Abbott (ABT) Laps the Stock Market: Here's Why
06:51pm, Friday, 03'rd Oct 2025
Abbott (ABT) reached $134.59 at the closing of the latest trading day, reflecting a +1.2% change compared to its last close.
Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?
10:31am, Friday, 03'rd Oct 2025
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Healthcare equipment stocks seen outperforming, ‘safer' than Big Pharma: analysts
01:04pm, Tuesday, 30'th Sep 2025
UBS analysts are ‘Overweight' the healthcare equipment sector, with a Number One ranking on their total scorecard. In a note to clients on Tuesday, the analysts wrote that healthcare equipme
